Interesting facts
Interesting Facts about 5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-anilino]-2-hydroxy-propyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
The compound in question showcases a fascinating structure that combines multiple functional groups and iodine atoms, which are integral to its chemical behavior and potential applications. Here are some noteworthy points about this compound:
- Iodine Involvement: The presence of tri-iodinated benzene rings suggests a strong potential for this compound in imaging applications, particularly in medical diagnostics such as X-ray imaging or computed tomography (CT) due to iodine’s high atomic number.
- Dual Action: The compound is designed with multiple active sites, allowing for targeted therapeutic use. This makes it a candidate for drug development aimed at specific biological targets, enhancing efficacy while minimizing side effects.
- Complex Structure: The intricate arrangement of various functional groups, including acetyl and carbamoyl, contributes to the compound’s overall stability and ability to interact with biological molecules. This complexity can influence its pharmacokinetics and pharmacodynamics.
- Potential Environmental Impact: The structural components may also raise questions about environmental safety and biocompatibility, requiring thorough investigation in the context of sustainable chemistry.
- Synthesis Challenges: The synthesis of such a complex molecule is likely to require sophisticated techniques and might involve multiple reaction steps, showcasing the depths of modern synthetic organic chemistry.
In summary, this compound exemplifies a robust intersection of technology and chemistry, with its multifaceted applications and intriguing properties paving the way for future research and innovation. As a chemistry student or scientist, recognizing the potential of such compounds can be immensely rewarding and inspiring.
Synonyms
iodixanol
92339-11-2
Visipaque
Indixanol
Iodixanolum
Visipaque 270
Visipaque 320
OptiPrep
Iodixanolum [Latin]
2-5410-3A
CCRIS 7567
UNII-HW8W27HTXX
HW8W27HTXX
NSC-760069
DTXSID2045523
CHEBI:31705
HSDB 8076
5,5'-((2-Hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)
2-541O-3A
5-[acetyl-[3-[N-acetyl-3,5-bis[[(2S)-2,3-dihydroxypropyl]carbamoyl]-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-1-N,3-N-bis[(2S)-2,3-dihydroxypropyl]-2,4,6-triiodobenzene-1,3-dicarboxamide
DTXCID0025523
EC 618-837-0
Iodixanol [USAN:USP:INN:BAN]
Iodixanolum (Latin)
NSC 760069
5,5'-((2-hydroxypropane-1,3-diyl)bis(acetylazanediyl))bis(N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)
IODIXANOL (MART.)
IODIXANOL [MART.]
IODIXANOL (USP-RS)
IODIXANOL [USP-RS]
1,3-Benzenedicarboxamide, 5,5'-((2-hydroxy-1,3-propanediyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
OptiPrep; Visipaque; Visipaque 270;2-5410-3A
IODIXANOL (EP MONOGRAPH)
IODIXANOL (USP IMPURITY)
IODIXANOL [EP MONOGRAPH]
IODIXANOL [USP IMPURITY]
IODIXANOL (USP MONOGRAPH)
IODIXANOL [USP MONOGRAPH]
Iodixanol (USAN:USP:INN:BAN)
SR-01000872678
Lodixanol
Visipaque (TN)
NCGC00016958-01
1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
5,5'-((2-hydroxypropane-1,3-diyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide)
5,5'-[(2-hydroxypropane-1,3-diyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide]
Iodixanol; 5,5'-[(2-hydroxypropane-1,3-diyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide]
CAS-92339-11-2
Visipaque;Iodixanolum
Iodixanol (Standard)
IODIXANOL [INN]
IODIXANOL [JAN]
IODIXANOL [MI]
IODIXANOL [USAN]
Prestwick0_000848
Prestwick1_000848
Prestwick2_000848
Prestwick3_000848
IODIXANOL [VANDF]
IODIXANOL [WHO-DD]
Iodixanol (JAN/USP/INN)
SCHEMBL21546
BSPBio_000835
5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
SPBio_002756
BPBio1_000919
IODIXANOL [ORANGE BOOK]
CHEMBL1200507
HY-B1426R
V08AB09
1,3-Bis(acetylamino)-N,N'-bis
HMS1570J17
HMS2097J17
HMS3714J17
Pharmakon1600-01503835
BCP11111
HY-B1426
Tox21_110711
MFCD00867965
NSC760069
AKOS015895607
Tox21_110711_1
AC-7610
AT38998
CCG-213207
DB01249
NCGC00179408-01
NCGC00179408-03
1,3-Benzenedicarboxamide, 5,5'-((2-hydroxy-1,3-propanediyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo)-, (16alpha)-
5-(Acetyl-(3-(acetyl-(3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl)amino)-2- hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; 5,5'-((2-hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide);
MS-32198
AB00513936
CS-0013137
NS00001497
D01474
AB00513936_02
A844203
EN300-18167324
Q2419291
SR-01000872678-1
SR-01000872678-2
BRD-A08660406-001-01-8
BRD-A08660406-001-05-9
OptiPrep(TM) Density Gradient Medium, used for cell and subcellular organelle isolation
1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3- propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodo-
5,5'-(2-hydroxypropane-1,3-diyl)bis(acetylazanediyl)bis(N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)
5,5-[(2-Hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
5-(Acetyl-(3-(acetyl-(3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl)amino)-2-hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; 5,5'-((2-hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide);
5-[[3-[[3,5-bis[2,3-bis(oxidanyl)propylcarbamoyl]-2,4,6-tris(iodanyl)phenyl]-ethanoyl-amino]-2-oxidanyl-propyl]-ethanoyl-amino]-N1,N3-bis[2,3-bis(oxidanyl)propyl]-2,4,6-tris(iodanyl)benzene-1,3-dicarboxamide
5-[acetyl-[3-[N-acetyl-3,5-bis[(2,3-dihydroxypropylamino)-oxomethyl]-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
A diastereomeric mixture of 5,5'-((2-hydroxy-trimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
Solubility of 5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-anilino]-2-hydroxy-propyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide (C35H44I6N6O15)
The solubility of this complex organoiodine compound can be influenced by a variety of factors:
It is essential to note that, "the more hydrogen bonds a compound can form with a solvent, the greater its solubility in that solvent." Therefore, the solubility of this compound is likely to be moderate in aqueous environments but may vary when tested against different solvent conditions. Exploring its solubility is crucial for its applications in pharmaceutical and chemical industries, where effective formulation depends heavily on solubility properties.